{
    "Case ID": "001947",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent validity and infringement"
    ],
    "Legal_Issue": [
        "Infringement of Canadian Patent No. 2,629,670; validity based on non-obviousness and utility"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations",
        "Patent Act"
    ],
    "Procedural_Stage": [
        "Judicial review"
    ],
    "Evidence_Assessment": [
        "Expert evidence and affidavits on dissolution profiles, binder composition, prior art, and utility"
    ],
    "Decision_Outcome": [
        "No infringement; patent invalid"
    ],
    "Burden_of_Proof": [
        "On Servier to prove infringement and validity"
    ],
    "Credibility_Factor": [
        "Court relied on expert testimony and technical evidence"
    ],
    "Legal_Rule": [
        "A patent is infringed if all essential elements of the claim are present; patent must meet requirements of non-obviousness and utility"
    ],
    "Standard_of_Review": [
        "Statutory review under PM(NOC) Regulations"
    ],
    "Procedural_Issue": [
        "Compliance with PM(NOC) procedural requirements"
    ],
    "Grounds_for_Claim": [
        "Alleged infringement of '670 Patent by Apotex's generic gliclazide tablets"
    ],
    "Outcome_on_Merits": [
        "Claim dismissed; no infringement and patent invalid"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed with costs to Apotex"
    ],
    "Review_Standard": [
        "Statutory interpretation and factual assessment"
    ],
    "Procedural_Fairness_Assessment": [
        "Full hearing with evidence and submissions considered"
    ],
    "Key_Evidence_Considered": [
        "Dissolution profile data",
        "Formulation differences (absence of defined binder)",
        "Prior art references",
        "Utility demonstration or prediction"
    ],
    "Legal_Framework": [
        "PM(NOC) Regulations framework for generic drug approval and patent disputes"
    ],
    "Applicant_Challenge": [
        "Servier sought prohibition of Apotex's product approval"
    ],
    "Court_Result": [
        "Dismissal of application; Apotex entitled to Notice of Compliance"
    ],
    "Legal_Rule_Source": [
        "Patent Act",
        "Case law on obviousness and utility"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Denial of infringement; challenge to patent validity"
    ],
    "Evidence_Type": [
        "Affidavits",
        "Expert reports",
        "Scientific testing data"
    ],
    "Remedy_Requested": [
        "Prohibition of Apotex's generic product from entering market"
    ],
    "Outcome": [
        "Remedy denied; Apotex may proceed with marketing upon regulatory approval"
    ],
    "Decision_Authority": [
        "Minister of Health, following court decision"
    ],
    "Remedy_Sought": [
        "Interim injunction equivalent via NOC prohibition"
    ],
    "Resolution_Mechanism": [
        "Judicial determination under PM(NOC) proceedings"
    ],
    "Legal_Provision": [
        "Section 6 of PM(NOC) Regulations",
        "Patent Act provisions on infringement and validity"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Patentee (Servier)"
    ],
    "Legal_Provision_Cited": [
        "Canadian Patent No. 2,629,670",
        "Patent Act",
        "PM(NOC) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Infringement based on formulation and dissolution profile"
    ],
    "Applicable_Process": [
        "Section 6(1) PM(NOC) application"
    ],
    "Outcome_of_Review": [
        "Application dismissed"
    ],
    "Pending_Relief_or_Application": [
        "Request for prohibition of generic approval"
    ],
    "Jurisdiction": [
        "Federal jurisdiction â€“ intellectual property"
    ],
    "Governing_Rule": [
        "PM(NOC) Regulations and Patent Act"
    ]
}